Whither pharmacometrics?: present state and future choices.

about

Multiscale Modeling in the Clinic: Drug Design and Development

P2860

Q38736948-91D184B6-9D89-443E-BC74-1EFD6BF50121

P2860

Whither pharmacometrics?: present state and future choices.

Item

http://www.wikidata.org/entity/Q39189602

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Whither pharmacometrics?: present state and future choices.

@en

Whither pharmacometrics?: present state and future choices.

@nl

type

Item

label

Whither pharmacometrics?: present state and future choices.

@en

Whither pharmacometrics?: present state and future choices.

@nl

prefLabel

Whither pharmacometrics?: present state and future choices.

@en

Whither pharmacometrics?: present state and future choices.

@nl

P1476

Whither pharmacometrics?: present state and future choices.

@en

P2093

B P Smith

http://www.w3.org/2001/XMLSchema#string

P Vicini

http://www.w3.org/2001/XMLSchema#string

P2860

Population pharmacokinetics of azithromycin in whole blood, peripheral blood mononuclear cells, and polymorphonuclear cells in healthy adults.

Simulation of clinical trials.

Drug treatment effects on disease progression.

Pharmacokinetic/pharmacodynamic studies in drug product development.

How modeling and simulation have enhanced decision making in new drug development.

Pharmacokinetics/Pharmacodynamics and the stages of drug development: role of modeling and simulation.

Impact of pharmacometric reviews on new drug approval and labeling decisions--a survey of 31 new drug applications submitted between 2005 and 2006.

Pharmacometrics at FDA: evolution and impact on decisions.

Pharmacometrics: a multidisciplinary field to facilitate critical thinking in drug development and translational research settings.

Use of pharmacokinetic/ pharmacodynamic modelling for starting dose selection in first-in-human trials of high-risk biologics.

P2888

clpt.2014.72

P304

567-571

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CLPT.2014.72

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1039588134

http://www.w3.org/2001/XMLSchema#string

P698

24842634

http://www.w3.org/2001/XMLSchema#string

Whither pharmacometrics?: present state and future choices.

about

P2860

P2860

Whither pharmacometrics?: present state and future choices.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698